Senzime AB (publ), announced on June 1 that the company has entered into an agreement to acquire the US company Respiratory Motion. Following this announcement, Senzime invites investors, analysts, and media to an webcast (in English) with a Q&A-session on June 2, at 11:00 a.m. CEST.
The presentation will be held by Senzime's CEO Pia Renaudin, Philip Siberg, Chairman of the Board, Jonathan Ekman, Head of M&A and Professor Lars I Eriksson from the section for Anesthesiology and Intensive Care at the Department of Physiology and Pharmacology at Karolinska University Hospital. The webcast will conclude with a Q&A session. No preregistration is required.
Date and time
June 2, 2022, at 11:00 a.m. CEST
The webcast will also be available on demand on Senzime’s corporate website after the event.